Re: Why didn't management do some phase 2's,....
in response to
by
posted on
Jun 19, 2019 06:53PM
I just looked it up, the EAMINE and ELIXA trials both had dropout rates around the 20-25% mark so BDAZ’s estimate for dropout rate is quite reasonable.